Alzheimer’s Research UK Conference 2018: Day 1

4 Apr 2018

Written by Huzefa Rupawala (Kings College London, UK)

Conferences Neurodegeneration and degenerative disease

Alzheimer’s disease (AD) is the most common form of age-related dementia. Currently affecting 50 million people worldwide, this number is set to rise to 152 million by 2050. With an ever-increasing necessity for better treatments and therapies, research is vital to validate new drug targets, identify potential mechanisms and improve the success of clinical trials. The Alzheimer’s Research UK (ARUK) Conference 2018 commenced in the heart of London at the iconic Queen Elizabeth II Centre. The conference encompassed the progressive research undertaken by institutions across the UK, with a mission to prevent, treat and hopefully find a cure for dementia....